Globus Medical
(NYSE) GMED
Globus Medical Financials at a Glance
Market Cap
$11.55B
Revenue (TTM)
$3.10B
Net Income (TTM)
$586.74M
EPS (TTM)
$4.29
P/E Ratio
19.82
Dividend
$0.00
Beta (Volatility)
0.99 (Low)
Dividend
$0.00
Beta (Volatility)
0.99 (Low)
Price
$85.02
Volume
87
Open
$85.26
Price
$85.02
Volume
87
Open
$85.26
Previous Close
$85.10
Daily Range
$84.03 - $85.73
52-Week Range
$51.79 - $101.40
Dividend
$0.00
Beta (Volatility)
0.99 (Low)
Price
$85.02
Volume
87
Open
$85.26
Previous Close
$85.10
Daily Range
$84.03 - $85.73
52-Week Range
$51.79 - $101.40
GMED News
Investing in Life Sciences Stocks
GMED: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Globus Medical
Industry
Healthcare Equipment and Supplies
Sector
Health CareEmployees
6,000
CEO
Keith W. Pfeil, EMBA
Website
www.globusmedical.comHeadquarters
Audubon, PA 19403, US
GMED Financials
Key Financial Metrics (TTM)
Gross Margin
68%
Operating Margin
18%
Net Income Margin
19%
Return on Equity
13%
Return on Capital
11%
Return on Assets
11%
Earnings Yield
5.05%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$11.55B
Shares Outstanding
135.67M
Volume
87
Avg. Volume
1.31M
Financials (TTM)
Gross Profit
$1.98B
Operating Income
$479.80M
EBITDA
$729.90M
Operating Cash Flow
$753.45M
Capital Expenditure
-$164.68M
Free Cash Flow
$588.77M
Cash & ST Invst.
$557.24M
Total Debt
$118.66M
Globus Medical Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$759.85M
+27.0%
Gross Profit
$525.79M
+30.6%
Gross Margin
69.20%
N/A
Market Cap
$11.55B
N/A
Market Cap/Employee
$2.18M
N/A
Employees
5,300
N/A
Net Income
$124.30M
+64.7%
EBITDA
$233.43M
+42.2%
Quarterly Fundamentals
Net Cash
$514.63M
+39.5%
Accounts Receivable
$686.43M
+27.6%
Inventory
$772.60M
+16.4%
Long Term Debt
$100.10M
+22.5%
Short Term Debt
$15.12M
+42.4%
Return on Assets
10.79%
N/A
Return on Invested Capital
11.02%
N/A
Free Cash Flow
$162.75M
+19.5%
Operating Cash Flow
$202.36M
+14.1%